header logo image

Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

April 15th, 2023 12:16 am

PHILADELPHIA, April 13, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Steven Nichtberger, M.D., Chief Executive Officer, will present a company presentation at the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20, 2023 at 9:30 a.m. ET.

More here:
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick